High‐level expression of full‐length antibodies using trans‐complementing expression vectors

Authors:

Abstract
Recombinant antibodies are increasingly used as therapeutics for a wide variety of diseases. Generation of cell lines expressing high levels of recombinant antibody typically requires labor‐intensive cloning and screening steps. We describe a mammalian expression system for the high‐level production of full‐length antibody molecules. It has been shown that the dihydrofolate reductase (DHFR) selectable marker can be divided into two fragments that, with the aid of a leucine zipper, can re‐associate to form an active molecule. Using bicistronic vectors, we linked the expression of each antibody chain to the expression of a DHFR fragment. Survival in selective media requires expression of both DHFR fragments that, by virtue of these vectors, also selects for the expression of both antibody chains. Initial pools produced 5 µg of Ab/106 cells/d (qP = µg/106 cells/d). Expression of each antibody chain in conjunction with a portion of DHFR also leads to concurrent amplification of both antibody chains in the presence of methotrexate, a DHFR inhibitor, and results in a two‐ to fivefold increase in antibody production with basal qPs ranging from 10–25 ug/106 cells/d. Shake‐flask cultures of amplified pools produced up to 600 mg/L of antibody in 7 days. This system allows for rapid generation of antibodies without cloning and greatly simplifies selection of cell lines for the production of potential antibody therapeutics. © 2003 Wiley Periodicals, Inc. Biotechnol Bioeng 84: 439–444, 2003.

This publication has 15 references indexed in Scilit: